CHAUHAN JYOTI enters LANDOS BIOPHARMA, INC. with 91.25K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/3/2021ACC: 0001209191-21-007437
Officer· ED, Global Clinical Operations
Since Feb 2021
91.25K
Baseline shares
100% direct
91.25K
Direct ownership
1 position
273.74K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned91.25K
Total
91.25K direct91.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 91.25K | Direct |
| Total | 91.25K | 91.25K direct |
Derivative Holdings1
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
273.74K
Shares owned
N/A
Exercise price
1.86
Expiration
—
Exercise window
—
Total
Underlying
273.74K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 1.86 | — | — | 273.74K | N/A |
| Total | 273.74K | 0.00 | ||||